6月9日中欧医疗健康混合A净值增长2.59%，今年来累计上涨8.71%

Group 1 - The core viewpoint of the news is the performance and holdings of the China Europe Medical Health Mixed A Fund, which has shown positive growth in its net value and returns over various time frames [1] - As of June 9, 2025, the latest net value of the fund is 1.7495 yuan, reflecting a growth of 2.59% [1] - The fund's one-month return is 6.87%, ranking 260 out of 4686 in its category, while the three-month return is 6.84%, ranking 404 out of 4628 [1] - Year-to-date, the fund has achieved a return of 8.71%, with a ranking of 1149 out of 4564 [1] Group 2 - The top ten stock holdings of the China Europe Medical Health Mixed A Fund account for a total of 55.30%, with significant positions in companies such as Heng Rui Pharmaceutical (10.60%) and WuXi AppTec (9.95%) [1] - Other notable holdings include Kanglong Chemical (6.24%), Mindray Medical (5.21%), and Tiger Medical (5.04%) [1] - The fund was established on September 29, 2016, and as of March 31, 2025, it has a total scale of 15.613 billion yuan, managed by fund manager Ge Lan [1] Group 3 - Ge Lan, the fund manager, holds a PhD in Biomedical Engineering from Northwestern University and has extensive experience in the investment management field [2] - Ge Lan has previously worked as a researcher at Guojin Securities and Minsheng Jia Yin Fund Management, and has managed multiple funds since joining China Europe Fund Management in October 2014 [2]